Subscribe By E-Mail

CytRx Receives NASDAQ Extension – MarketWatch (press release)

CytRx Receives NASDAQ Extension
MarketWatch (press release)
LOS ANGELES, Apr 23, 2012 (BUSINESS WIRE) — CytRx Corporation (UTD:CYTR) , a biopharmaceutical company specializing in oncology, today announced that it has received a favorable ruling from the NASDAQ Hearings Panel (the "Panel"), whereby the Panel

and more »

nasdaq – Google News